IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Phase 2 biotech developing intranasal and oral therapies for brain cancer.
Industry: Health Care
Latest Trade: ()
First Day Return:
Return from IPO:
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 12/18/2023 |
Offer Price | |
Price Range $11.25 - $13.75 | |
Offer Shares (mm) | 6.0 |
Deal Size ($mm) | $75 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | |
Offer Price | |
Price Range $11.25 - $13.75 | |
Offer Shares (mm) | 6.0 |
Deal Size ($mm) | $75 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Loop Capital Markets |
Maxim Group LLC |
more |
Company Data | |
---|---|
Headquarters | Westlake Village, CA, United States |
Founded | 2008 |
Employees | 8 |
Website www.neonctech.com |